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Sarbecoviruses have emerged twice in the 21st 
century, causing a worldwide epidemic and pan-
demic. The ongoing pandemic of coronavirus dis-
ease 2019 (Covid-19), the disease caused by severe 
acute respiratory syndrome coronavirus 2 (SARS-
CoV-2), has caused unprecedented disruption of 
human society. Since its emergence in December 
2019, SARS-CoV-2 has spread worldwide, infect-
ing more than 70 million persons and causing 
more than 1.6 million deaths as of early Decem-
ber 2020. Previous studies have clearly shown that 
epidemic and pandemic RNA virus spread may 
select for mutations that alter RNA virus patho-
genesis, virulence, transmissibility, or a combina-
tion of these,1 yet this process remains poorly 
studied among emerging coronaviruses in animals 
and humans.
SARS-CoV-2 probably emerged from bats, and 
early strains identified in Wuhan, China, showed 
limited genetic diversity, which suggests that the 
virus may have been introduced from a single 
source.2 Early zoonotic variants in the novel coro-
navirus SARS-CoV that emerged in 2003 affected 
the receptor-binding domain (RBD) of the spike 
protein and thereby enhanced virus docking and 
entry through the human angiotensin-converting–
enzyme 2 (hACE2) receptor.3 In contrast, the spike-
protein RBD of early SARS-CoV-2 strains was 
shown to interact efficiently with hACE2 receptors 
early on.2
However, despite the presence of a CoV RNA 
proofreading activity that yields high replication 
fidelity, genetic epidemiologic investigations con-
ducted in late February identified an emerging 
D614G mutation affecting the spike glycoprotein 
of SARS-CoV-2 strains from southern Europe; 
this variant has since spread rapidly and has be-
come the most prevalent genotype worldwide.4 
Patients infected with D614G-associated SARS-
CoV-2 are more likely to have higher viral loads 
in the upper respiratory tract than patients in-
fected with virus strains without the mutation, 
but disease severity is not affected. Pseudotyped 
viruses with the G614 form of the SARS-CoV-2 
spike protein have been reported to exhibit in-
creased infectivity in continuous cell lines and 
increased sensitivity to neutralization. In addi-
tion, structural analyses have revealed that the 
RBD of the G614 form of the spike protein is 
more likely to assume an “open” conformation 
than the RBD of the ancestral D614 form, imply-
ing an improved ability to bind to the hACE2 
receptor. However, published reports of isolation 
of the D614G substitution in an authentic SARS-
CoV-2 recombinant live virus are lacking, as are 
investigations on the effects of the mutation on 
in vivo replication and pathogenesis.
In a recent study, Plante et al. used reverse 
genetics to recover isogenic recombinant SARS-
CoV viruses encoding the D614G mutation.5 The 
G614 variant replicated more efficiently than did 
the D614 variant in immortalized cells in culture 
and in primary human airway epithelial cells 
(Fig. 1A and 1B). Even at D614-to-G614 variant 
infection ratios of 1:1, 3:1, or 9:1, the contempo-
rary G614 strain outcompeted the ancestral D614 
strain in primary human airway epithelial cells. 
The G614 variant also seemed to be more stable 
than the ancestral strain, which suggests that in-
creased stability may be associated with increased 
infectivity, although additional investigations will 
be needed to confirm this finding.
In studies in hamsters infected with D614 or 
G614 variants, Plante et al. showed that the con-
temporary G614 variant replicated to higher titers 
in nasal-wash samples early after infection and 
outcompeted the ancestral D614 variant (Fig. 1C); 
these findings suggest increased fitness in a major 
upper airway compartment potentially associated 
with enhanced transmission. The SARS-CoV-2 
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G614 variant did not cause more severe disease 
than the ancestral strain in hamsters, a finding 
that supports current findings in humans. The 
Covid-19 vaccines that are currently being evalu-
ated in clinical trials are based on the original 
D614 ancestral spike sequence; therefore, the 
authors used a panel of serum specimens to test 
whether the G614 variant is as sensitive to neu-
tralization as the ancestral strain (Fig. 1D). Fortu-
nately, the results showed that it is as sensitive to 
the serum specimens as the D614 strain and thus 
may allay fears that it could escape vaccine-
elicited immunity.
Plante et al. have provided evidence of the 
genetic and molecular basis for enhanced fitness 
of the G614 variant over ancestral strains, pro-
viding strong support for its role in facilitating 
global spread. Unlike variants in the SARS-CoV 
2003 epidemic strain, those in SARS-CoV-2 may 
point to new mechanisms that are associated 
with pandemic spread in human populations. In 
addition to showing the critical importance of 
blending genetic epidemiologic studies with em-
pirical molecular virologic studies to understand 
pandemic virus evolution and spread, the find-
ings raise critical questions regarding the future 
evolutionary trajectories of the SARS-CoV-2 G614 
variant. These questions are especially important 
at a time when environmental pressures, such as 
expanding herd immunity, vaccine-induced im-
munity, antiviral therapies, and public health inter-
vention strategies, may — through selective pres-
sure — promote virus survival and escape. Will 
these selective pressures drive antigenic variation, 
promote virus stability and transmissibility, alter 
virus virulence and pathogenesis, or drive SARS-
CoV-2 to extinction or into alternative hosts as 
reservoirs? Plante et al. articulate a critical need 
for proactive, rather than reactive, tracking of 
SARS-CoV-2 and other potential emerging coro-
naviruses.
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Figure 1 (facing page). Increased Infectivity of SARS-
CoV-2 Bearing the Spike Protein D614G Substitution.
A study recently reported by Plante et al.5 showed that 
a variant of SARS-CoV-2 carrying the spike protein 
D614G substitution results in increased virus infectivi-
ty and yield in human lung epithelial cells (Panel A), in 
primary human airway tissue (Panel B), and in the up-
per airway of hamsters (Panel C). These data suggest 
that the D614G mutation results in enhanced transmis-
sibility. In addition, serum samples from D614-virus–
infected hamsters can efficiently neutralize the G614 
virus from infecting cells (Panel D), which suggests 
that SARS-CoV-2 vaccines, all of which are based on 
the D614 variant of the spike protein, will protect 
against G614 variants of the virus.
